BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1461581)

  • 21. Omeprazole.
    Langman MJ
    Aliment Pharmacol Ther; 1991 Aug; 5(4):357-64. PubMed ID: 1777546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
    Castell D
    Expert Opin Pharmacother; 2005 Nov; 6(14):2501-10. PubMed ID: 16259581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study.
    Montemurro NE; Di Maggio A; Loperfido A; Franceschi M; Scatizzi A
    Clin Nephrol; 1993 Nov; 40(5):296-8. PubMed ID: 8281719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
    Lampkin TA; Ouellet D; Hak LJ; Dukes GE
    DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric therapy for gastroesophageal reflux disease.
    Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
    Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic evaluation of omeprazole.
    Adams MH; Ostrosky JD; Kirkwood CF
    Clin Pharm; 1988 Oct; 7(10):725-45. PubMed ID: 3069285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of gastroesophageal reflux disease.
    Kaplan B; Koppelo KL
    W V Med J; 1994 Dec; 90(12):510-7. PubMed ID: 7863640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
    Fiorucci S; Santucci L; Morelli A
    Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
    Schulman MI; Orlando RC
    Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
    [No Abstract]   [Full Text] [Related]  

  • 33. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

  • 35. Proton pump inhibitors and acid-related diseases.
    Sachs G
    Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole: blocks gastric acid secretion completely.
    Drug Ther Bull; 1990 Jun; 28(13):49-52. PubMed ID: 2131211
    [No Abstract]   [Full Text] [Related]  

  • 38. Overview of medical therapy of peptic ulcer disease.
    Freston JW
    Gastroenterol Clin North Am; 1990 Mar; 19(1):121-40. PubMed ID: 2184124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP; Johnston BT; Just RJ; Castell DO
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.